Hydralazine injection
Last Updated: April 14, 2020
Status: Current
Products Affected - Description
-
- Hydralazine injection, Akorn, 20 mg/mL, 1 mL vial, 25 count, NDC 17478-0934-15
- Hydralazine injection, X-Gen, 20 mg/mL, 1 mL vial, 25 count, NDC 39822-0500-04
Reason for the Shortage
-
- Akorn did not provide a reason for the shortage.
- American Regent is not currently marketing hydralazine injection.
- Fresenius Kabi has hydralazine available.
- X-Gen did not provide a reason for the shortage.
Available Products
-
- Hydralazine injection, Fresenius Kabi, 20 mg/mL, 1 mL vial, 25 count, NDC 63323-0614-01
Estimated Resupply Dates
-
- Akorn has hydralazine 20 mg/mL 1 mL vials on back order and the company estimates a release date of early-May 2020. The company is allocating upon release.
- X-Gen has hydralazine 20 mg/mL 1 mL vials on back order and the company cannot estimate a release date.
Updated
Updated April 14, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. Created June 4, 2018 by Anthony Trovato, PharmD, BCPS. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
